UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000036570
Receipt number R000041617
Scientific Title Prospective and exploratory study for disease specific biomarkers and objective indicators in neurodegenerative diseases
Date of disclosure of the study information 2019/04/22
Last modified on 2023/04/11 14:23:37

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Prospective and exploratory study for disease specific biomarkers and objective indicators in neurodegenerative diseases

Acronym

Prospective study for biomarkers in neurodegenerative diseases

Scientific Title

Prospective and exploratory study for disease specific biomarkers and objective indicators in neurodegenerative diseases

Scientific Title:Acronym

Prospective study for biomarkers in neurodegenerative diseases

Region

Japan


Condition

Condition

All Neurodegenerative diseases specifically Parkinson's disease, corticobasal degeneration and progressive supranuclear palsy

Classification by specialty

Neurology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This study is to establish imaging, biochemical or physiological biomarkers, which can provide diagnosis, staging and prediction for prognosis of neurodegenerative diseases including/?specifically Parkinson's syndrome/?parkinsonian symptoms

Basic objectives2

Others

Basic objectives -Others

Exploratory

Trial characteristics_1

Exploratory

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

Assessment of parkinsonism (MDS-UPDRS score, Hoehn-Yahr stage)

Key secondary outcomes

Cognitive evaluation (MMSE, Visual Perspective test, etc.), Brain imaging evaluation (structural MRI , functional MRI, etc.) and biochemical markers of cerebrospinal fluid and serum (catecholamine concentration, alpha-synuclein concentration, cerebrospinal fluid amyloid aggregation, etc.)


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients over 18 years old with parkinsonism, who provided (by own or by a representative) a written informed consent. Parkinsonism is defined as two or more symptoms in tremor, akinesia, muscular rigidity, and postural reflex disorder, which show a slow progressive course. As a disease control, this study also targets at patients who receive spinal fluid drainage to prevent spinal cord ischemia among thoracoabdominal surgery.

Key exclusion criteria

None

Target sample size

600


Research contact person

Name of lead principal investigator

1st name Hideki
Middle name
Last name Mochizuki

Organization

Osaka University Graduate School of Medicine

Division name

Neurology

Zip code

565-0871

Address

2-2, Yamadaoka, Suita City, Osaka Prefecture

TEL

+(81)-6-6879-3571

Email

crgou@neurol.med.osaka-u.ac.jp


Public contact

Name of contact person

1st name Kotaro
Middle name
Last name Ogawa

Organization

Osaka University Graduate School of Medicine

Division name

Neurology

Zip code

565-0871

Address

2-2, Yamadaoka, Suita City, Osaka Prefecture

TEL

+(81)-6-6879-3571

Homepage URL


Email

crgou@neurol.med.osaka-u.ac.jp


Sponsor or person

Institute

Department of Neurology, Osaka University Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Japan Science and Technology Agency

Organization

Division

Category of Funding Organization

Government offices of other countries

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Osaka University Clinical Research Review Committee

Address

Center of Medical Innovation and Translational Research 4F, 2-2, Yamadaoka, Suita City, Osaka Prefecture

Tel

06-6210-8289

Email

rinri@hp-crc.med.osaka-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 04 Month 22 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2014 Year 05 Month 08 Day

Date of IRB

2014 Year 05 Month 08 Day

Anticipated trial start date

2014 Year 05 Month 08 Day

Last follow-up date

2025 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Patients over 18 years old with parkinsonism, who provided (by own or by a representative) a written informed consent. Parkinsonism is defined as two or more symptoms in tremor, akinesia, muscular rigidity, and postural reflex disorder, which show a slow progressive course. As a disease control, this study also targets at patients who receive spinal fluid drainage to prevent spinal cord ischemia among thoracoabdominal surgery.
Recruitment is conducted for patients who visit Department of Neurology, Osaka University Hospital after May 8, 2014.


Management information

Registered date

2019 Year 04 Month 22 Day

Last modified on

2023 Year 04 Month 11 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041617


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name